LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.30 | 21.74 | 5 | 6244 | 0.0008 | -0.1647 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.30 | 21.74 | 9812 | 6244 | 1.5713 | 1.1138 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.30 | 21.74 | 644 | 6244 | 0.1031 | 0.5143 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.30 | 21.74 | 7396 | 6244 | 1.1844 | 1.0419 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.27 | 21.74 | 4 | 6201 | 0.0006 | -0.1874 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.27 | 21.74 | 10143 | 6201 | 1.6355 | 1.1243 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.27 | 21.74 | 483 | 6201 | 0.0779 | 0.4626 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.27 | 21.74 | 7640 | 6201 | 1.2319 | 1.0518 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.24 | 21.74 | 9 | 6162 | 0.0015 | -0.1026 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.24 | 21.74 | 10361 | 6162 | 1.6814 | 1.1317 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.24 | 21.74 | 337 | 6162 | 0.0547 | 0.4000 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.24 | 21.74 | 7811 | 6162 | 1.2676 | 1.0591 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.21 | 21.74 | 11 | 6235 | 0.0018 | -0.0801 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.21 | 21.74 | 10697 | 6235 | 1.7155 | 1.1367 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.21 | 21.74 | 227 | 6235 | 0.0364 | 0.3329 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.21 | 21.74 | 8028 | 6235 | 1.2875 | 1.0629 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.18 | 21.74 | 6 | 6114 | 0.0010 | -0.1464 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.18 | 21.74 | 10985 | 6114 | 1.7966 | 1.1493 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.18 | 21.74 | 132 | 6114 | 0.0216 | 0.2482 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.18 | 21.74 | 8082 | 6114 | 1.3218 | 1.0698 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.15 | 21.74 | 8 | 6167 | 0.0013 | -0.1155 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.15 | 21.74 | 11072 | 6167 | 1.7952 | 1.1489 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.15 | 21.74 | 139 | 6167 | 0.0225 | 0.2557 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.15 | 21.74 | 8243 | 6167 | 1.3365 | 1.0725 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.12 | 21.74 | 7 | 6211 | 0.0011 | -0.1297 | MN20160310_N01 | I15 |